Rocket VR Health Chosen for Newchip’s Seed-Stage Global Accelerator Program
Rocket VR Health, a digital therapeutics company developing immersive therapy programs for cancer patients and survivors, has been accepted into Newchip’s renowned global accelerator program designed to provide all the skills and tools seed-stage founders need to rapidly fund, build, and scale their companies. The equity-free, fully digital accelerator has helped over 1,500 founders from more than 50 countries and 250 cities raise over $450M in funding with an estimated portfolio of over $9B.
“Newchip evaluates a vast and diverse number of seed-stage companies from around the globe, selecting only a small percentage to be part of our Seed Accelerator program,” said Armando Vera Carvajal, vice president of product at Newchip. “This careful vetting process of both the business model and founders makes us an ideal partner for venture capital investors and other key stakeholders in early-stage startup financings who are looking for promising startups that are beginning to generate traction and revenue. Innovative healthcare technology companies like Rocket VR Health can scale quickly with proper funding and guidance. We are excited for Rocket VR Health and believe they will be well positioned to take advantage of our fast-expanding global ecosystem at Newchip.”
Founded in 2020, Rocket VR Health is a tech startup developing a suite of immersive virtual reality (VR) therapy programs intended to achieve meaningful clinical improvements in the mental health of cancer patients and survivors. Rocket VR Health is on a mission to make mental healthcare in cancer more engaging, accessible, and fun. The company is working to deliver the next generation of digital therapeutics by leveraging proven clinical protocols transformed into gamified activities, meditations and on-demand therapy experiences taking place in beautiful 3D nature environments.
Since its founding, the company has assembled a team composed of leading oncologists, Hollywood animators, game designers, and VR engineers. With multiple collaborations with top cancer institutions underway, the company says it is committed to contributing to cutting-edge research and the adoption of VR within healthcare.
“We are pleased to take part in Newchip Accelerator and are looking forward to working with their industry experts, mentors and advisors to accelerate our company’s growth,” says Nik Vassev, COO and co-founder of Rocket VR Health. “This partnership will allow us to continue developing innovative tools for patients at every step of their cancer journey.”